Progenika Gives Grifols Rights to Distribute Bloodchip | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Spanish biotech Progenika Biopharma has granted exclusive worldwide distribution rights to Grifols for its Bloodchip product line, Progenika announced today.

The chips are used for genotyping blood donors to assure compatibility between donor and recipient. Progenika and the Bloodgen Consortium, which consists of European blood banks and research institutes, developed the chips.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.